- Poster presentation
- Open Access
Intracerebroventricular administration of Pasipay, the hydroalcoholic extract of Passiflora incarnata, suppresses epileptic seizures in rats
© Rad et al.; licensee BioMed Central Ltd. 2008
- Published: 17 April 2008
- Anxiety Disorder
- Epileptic Seizure
Passion flower (Passiflora incarnata) is used in traditional medicine of Europe and South America to treat anxiety, insomnia and seizure; its hydroalcoholic extract, Pasipay has been established in treating the physical symptoms of opioid withdrawal in human, anxiety disorders and ADHD [1–3]. Recently, it has shown anticonvulsant effects in mice .
Adult male rats were cannulated into intracerebroventricular (i.c.v). The anticonvulsant effects of rutin were investigated using the pentylenetetrazole (PTZ)-induced seizure model. The animals were placed individually in plastic boxes and observed immediately after PTZ injection for a period of 30 min. Pasipay, diazepam and normal saline were injected i.c.v. at the doses (0.125, 0.25, 0.55,1.1 mg/kg), (10 ml/kg) and (5 mg/kg) respectively 30 minutes before PTZ (90 mg/kg, i.p). The latency to minimal clonic seizure (MCS), generalized tonic-clonic seizure (GTCS) and percent of mortality protection were recorded, as well as the percentages of protection against the mortality.
Also, for investigating the mechanism of Pasipay, flumazenil (5 mg/kg) and naloxone (10 mg/kg) were also injected 5 minutes before rutin.
In this study, in PTZ-induced epileptic seizures, the i.c.v. injection of Pasipay at doses of 1.1 mg/kg prolonged the time MCS and reduced the GTCS latancy. The protective effect of rutin against lethality was 30%. In this study, flumazenil (5 mg/kg, i.c.v.) reversed the anticonvulsant activity of rutin. Also, pretreatment with naloxone (10 mg/kg, i.c.v.) antagonized the prolongation of tonic-clonic seizure latency as well as the reduction in seizure duration induced by Pasipay (200 mg/kg, i.c.v.).
These results indicate that Pasipay could be useful for treatment absence seizure and these effects may be related to effect of it on GABAergic and opioid systems. More studies are needed in order to investigate its exact mechanism.
The authors are thankful to the Vice Chancellor of Research, Qazvin University of Medical Sciences for financial support.
- Dhawan K, Dhawan S, Sharma A: Passiflora: a review update. J Ethnopharmacol. 2004, 94: 1-23. 10.1016/j.jep.2004.02.023.View ArticlePubMedGoogle Scholar
- Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M: Passionflower in the treatment of generalized anxiety disorder: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001, 26: 363-367. 10.1046/j.1365-2710.2001.00367.x.View ArticlePubMedGoogle Scholar
- Akhundzadeh S, Mohammadi MR, Momeni F: Passiflora incarnata in treatment of attention-deficit hyperactivity disorder in children and adolescents. Therapy. 2005, 2: 609-614.View ArticleGoogle Scholar
- Nassiri-Asl M, Shariati-Rad S, Zamansoltani F: Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors. BMC Complement Altern Med. 2007, 7-26.Google Scholar
This article is published under license to BioMed Central Ltd.